- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01813864
Linking Services to Patient Needs for Improved Patient Outcomes (CASPAR) (CASPAR)
The proposed Quality Improvement Initiative study is a health services research project in community-based substance abuse treatment programs. The primary goals are to use training and technology transfer to match services to client needs, increase the number of services received by clients, and improve client outcomes. This is a two phase study in which we compare clients pre-intervention to clients post-intervention.
Clients from Phase II (Post-Intervention) compared to Phase I (Pre-Intervention) will:have treatment plans that better match the problems reported at assessment; receive services that better match their needs, as reported during the assessment/intake; show better results during treatment performance on the Treatment Services Review (TSR), including attending a greater percentage of their scheduled treatment sessions and increased satisfaction with the Treatment Planning process; show better client outcomes at 3 month follow-up on primary drug and alcohol measures, including Breathalyzer and urine drug screen, and secondary personal health and social functioning measures such as days medical problems, days psychiatric problems, days employed, days of conflict with family members, etc.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This protocol will specifically target identified organizational barriers by implementing the CASPAR system as a site-wide Quality Improvement Initiative (QI Initiative) study and enrolling seven sites in Bucks and Montgomery Counties in Pennsylvania and in the Southern New Jersey region who (1) were the most active sites in participating in the focus groups and provided feedback that led to the development of the new Quality Improvement protocol, (2) want to focus organizational effort and attention on improving treatment planning and problem-services matching, (3) met additional inclusion criteria (detailed below). They are all located within Bucks and Montgomery Counties in Pennsylvania and within a 70 mile radius of Atlantic City, New Jersey.
Executive directors at all invited programs will sign a Letter of Agreement (LoA) with Treatment Research Institute (TRI) that as an organization they will support their counselors in attending training, providing individualized treatment plans as well as monthly individualized sessions dedicated to problem-service matching; will add items necessary to their assessment to make sure it is equally comprehensive as the Addiction Severity Index (ASI), and will allow TRI to recruit clients for follow-up to evaluate the effectiveness of the QI Initiative implementation. The LoA will detail all site-specific expectations, along with benefits to the program, including free counselor and supervisor training (along with Certified Addictions Counselor (CAC) and Certified Alcohol Drug Counselor (CADC) credits), free software, and monetary compensation, $2,000 for site participation in Phase I of the study and $3,000 for site participation in Phase II of the study. Directors will also be provided with a detailed Director Information Sheet outlining aspects of the Quality Improvement Initiative outlined in the LoA.
TRI staff will provide counselors and supervisors with the treatment planning training as well as the CASPAR Resource Guide software and training on its use. These activities will be initiated as an organization-wide Quality Improvement Initiative, and as such, will be implemented with all counselors at each program. No data will be collected from the counselors, nor will we discuss or report on client outcomes grouped by counselor.
This will be a 2-Phase project. TRI staff will recruit up to 6 eligible clients per counselor prior to providing the CASPAR training and up to 6 additional clients after providing training. Based on current data from the sites, we expect a minimum of 36 counselors to be involved in the Quality Improvement Initiative.
Update June 1st 2009 - Based on current recruitment levels achieved and analysis needs, we are projecting recruitment of approximately 320 subjects.
We will continue to evaluate the effectiveness of this enhanced protocol by addressing the same aims and using primarily the same client instruments previously approved by this Institutional Review Board (IRB, some have been modified, see full discussion below). We will compare client outcomes before (Phase I) and after the individualized treatment planning and problem-service matching components are introduced (Phase II). As before, we expect to see pre-post differences in problem-treatment plan matching, treatment plan-service matching, and in the number and appropriateness of services clients receive; we also expect to see pre-post differences in client outcome such as treatment attendance, treatment retention, breathalyzer, and urinalysis results, the same measures and outcomes in the original design.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New Jersey
-
Camden, New Jersey, United States, 08103
- SODAT
-
Cape May Court House, New Jersey, United States, 08210
- Cape Counseling
-
Collingswood, New Jersey, United States, 08108
- Genesis Counseling
-
Woodbury, New Jersey, United States, 08096
- SODAT
-
-
Pennsylvania
-
Bensalem, Pennsylvania, United States, 19020
- Aldie Counseling
-
Doylestown, Pennsylvania, United States, 19118
- Aldie Counseling
-
King Of Prussia, Pennsylvania, United States, 19406
- Malvern Institute
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- currently attending substance abuse treatment
Exclusion Criteria:
- incarceration
- under 18
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: CASPAR Resource Guide
Treatment Enhanced/CASPAR-- All counselors in this study will receive a training and take part in the experimental arm of the study in Phase 2.
|
All counselors in the study will receive additional training in treatment planning and the CASPAR Resource Guide software to easily identify and link patients to services not available at substance abuse treatment centers such as General Educational Development (GED) training, dental clinics, job training, etc.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Better client outcomes at 3 month follow-up on primary drug and alcohol measures
Time Frame: 3 months post treatment start.
|
3 months post treatment start.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Better client outcomes at 3 month follow-up on secondary personal health and social functioning measures such as days medical problems, days psychiatric problems, days employed, days of conflict with family members, etc.
Time Frame: 3-months post treatment start.
|
3-months post treatment start.
|
|
Increased satisfaction with the Treatment Planning process.
Time Frame: Assessed at 2, 4, 8 and 12 weeks.
|
Assessed at 2, 4, 8 and 12 weeks.
|
|
Improved match between patient problems and treatment plan & services received.
Time Frame: Up to 3-months post treatment start.
|
Improved match between:
|
Up to 3-months post treatment start.
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- R01DA015125 (U.S. NIH Grant/Contract)
- 5R01DA015125-05 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Substance Abuse
-
The Morton Center, Inc.National Institute on Alcohol Abuse and Alcoholism (NIAAA)UnknownAlcohol Dependence | Cannabis Dependence | Alcohol Abuse | Cannabis Abuse | Other Substance AbuseUnited States
-
National Health Promotion Associates, Inc.UnknownSubstance Use | Substance Abuse | Prescription Drug Abuse (Not Dependent)United States
-
National Health Promotion Associates, Inc.UnknownSubstance Use | Substance Abuse | Prescription Drug Abuse (Not Dependent)
-
Michael E. DeBakey VA Medical CenterUnknownAlcohol Dependence | Alcohol Abuse | Substance Abuse ProblemUnited States
-
National Institute on Drug Abuse (NIDA)CompletedDrug/Substance Abuse/Addiction | Alcohol Abuse/AddictionUnited States
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA)CompletedSubstance Abuse, IntravenousUnited States
-
Sheidow Consulting, Inc.Oregon Social Learning CenterCompletedSubstance Abuse ProblemUnited States
-
Penn State UniversityCompletedSubstance Abuse ProblemUnited States
-
National Institute on Drug Abuse (NIDA)CompletedSubstance Abuse | Drug Abuse | Alcohol AbuseUnited States
-
University of California, IrvineUS Department of Veterans AffairsWithdrawn
Clinical Trials on CASPAR/Treatment Planning
-
The Hong Kong Polytechnic UniversityCompletedTelerehabilitationHong Kong
-
University of ZurichSwiss National Science Foundation; SWPS University of Social Sciences and Humanities... and other collaboratorsUnknownPhysical Activity | Health Behavior | Adolescent BehaviorSwitzerland
-
Alberta Health servicesCompleted
-
Freie Universität BerlinDeutsche Krebshilfe e.V., Bonn (Germany)CompletedPhysical Activity | Health Behavior | CouplesGermany
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedGlioblastoma | Recurrent Brain NeoplasmUnited States
-
Montera Health Texas LLCNot yet recruitingAutism Spectrum Disorder
-
University of Wisconsin, MadisonActive, not recruitingStage II Prostate Adenocarcinoma | Stage I Prostate AdenocarcinomaUnited States
-
Universitaire Ziekenhuizen KU LeuvenCompleted
-
The Baruch Padeh Medical Center, PoriyaUnknownChronic Periodontitis
-
Indiana UniversityActive, not recruitingLung Cancer | Metastatic CancerUnited States